Market Size of Asia Pacific Pharmaceutical Blister Packaging Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 9.68 Billion |
Market Size (2029) | USD 13.16 Billion |
CAGR (2024 - 2029) | 6.32 % |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Asia Pacific Pharmaceutical Blister Packaging Market Analysis
The Asia Pacific Pharmaceutical Blister Packaging Market size is estimated at USD 9.68 billion in 2024, and is expected to reach USD 13.16 billion by 2029, growing at a CAGR of 6.32% during the forecast period (2024-2029).
The increasing incidence of new diseases, growth in regulatory norms, focus on people's health management, customers being more informed, and the increase in OTC drugs boost the growth of the pharmaceutical blister packaging market in the region.
- Extended shelf life is essential for the pharmaceutical sector, considering consumers store their drugs in a temperature-variant atmosphere that can harm unprotected medicines. Products include capsules, tablets, and sterile products.
- The growing population in developing countries such as India, rising health awareness, and increasing life expectancy can be attributed to the market's growth. The number of chronic disease cases is surging rapidly. According to WHO, over 20% of the country's population suffers from at least one of the chronic diseases, such as cancer, heart ailments, respiratory diseases, and diabetes, that are estimated to cost USD 6.2 trillion during the period 2012-2030. To prevent economic burdens in the coming years, pharmaceutical companies are researching and developing medicines to drive market growth.
- In August 2023, Aptar CSP Technologies partnered strategically with Porton Pharmatech to bring Activ-Blister solutions to the Asia-Pacific (APAC) region. The move followed the commercialization and approval of Activ-Blister technology with two HIV medications. The partnership with Porton provided pharma developers in the APAC region access to a local development and manufacturing resource for leveraging Aptar CSP's Activ-Blister solutions to protect sensitive drugs. Such collaborations drive market growth.
- In the pharmaceutical industry, blister packaging offers various solutions, such as PVC, PCTFE, PVDC, and thermoform blisters for less sensitive products. However, the unfitness for heavy items and stringent regulations in developing countries are anticipated to restrain market growth.
- Nationwide lockdowns, government regulations, and the steady rise in the national disease rate during the pandemic had far-reaching financial impacts on the market, especially in the early stages. However, the demand for packaging increased as the disease raised the demand for pharmaceutical products and concerns about the virus's ability to survive on the packaging surface.
Asia Pacific Pharmaceutical Blister Packaging Industry Segmentation
The pharmaceutical sector requires blister packaging solutions that are insulated from external surroundings, highly protected, cost-effective, and easy to handle. Moreover, blisters' unit dosage feature reduces the risk of incorrect dosing. Storing and handling the blister pack is convenient for commercial and household purposes, as the chances of damage are minimal.
The Asia-Pacific pharmaceutical blister packaging is segmented by material (plastic, paper, and aluminum), technology (cold forming and thermoforming), and country (China, India, Japan, Australia and New Zealand, and the Rest of Asia-Pacific). The report offers market sizes and forecasts in terms of value (USD) for all the above segments.
By Material | |
Plastic | |
Paper | |
Aluminum |
By Technology | |
Cold Forming | |
Thermoforming |
By Country*** | |
China | |
India | |
Japan | |
Australia and New Zealand |
Asia Pacific Pharmaceutical Blister Packaging Market Size Summary
The Asia Pacific pharmaceutical blister packaging market is poised for significant growth, driven by factors such as the increasing incidence of new diseases, heightened regulatory norms, and a growing focus on health management. The market is benefiting from the rise in over-the-counter (OTC) drugs and the need for extended shelf life to protect medicines stored in variable temperature conditions. The region's developing countries, particularly India, are experiencing population growth, rising health awareness, and increasing life expectancy, all contributing to the demand for pharmaceutical blister packaging. The surge in chronic diseases, such as cancer and diabetes, is prompting pharmaceutical companies to invest in research and development, further propelling market expansion. Strategic partnerships, like Aptar CSP Technologies' collaboration with Porton Pharmatech, are enhancing access to advanced packaging solutions, thereby supporting market growth.
The market landscape is characterized by a fragmented structure with key players such as Amcor Limited, Constantia Flexibles, and Westrock Company actively expanding their presence through acquisitions and collaborations. The focus on sustainability is evident with innovations like TekniPlex Healthcare's recyclable blister film and Constantia Flexibles' REGULA CIRC, which emphasizes circularity and compliance with future regulations. Government initiatives in countries like India, aimed at improving healthcare infrastructure and reducing healthcare costs, are expected to further drive market growth. The transformation of India's pharmaceutical supply chain, influenced by globalization and technological advancements, is also contributing to the market's expansion. As the region continues to evolve, the demand for sophisticated serialization and sustainable packaging solutions is likely to increase, ensuring the market's robust growth trajectory.
Asia Pacific Pharmaceutical Blister Packaging Market Size - Table of Contents
-
1. MARKET INSIGHTS
-
1.1 Market Overview
-
1.2 Industry Attractiveness - Porter's Five Forces Analysis
-
1.2.1 Bargaining Power Of Suppliers
-
1.2.2 Bargaining Power Of Buyers
-
1.2.3 Threat Of New Entrants
-
1.2.4 Threat Of Substitutes
-
1.2.5 Intensity Of Competitive Rivalry
-
-
1.3 Industry Value Chain Analysis
-
-
2. MARKET SEGMENTATION
-
2.1 By Material
-
2.1.1 Plastic
-
2.1.2 Paper
-
2.1.3 Aluminum
-
-
2.2 By Technology
-
2.2.1 Cold Forming
-
2.2.2 Thermoforming
-
-
2.3 By Country***
-
2.3.1 China
-
2.3.2 India
-
2.3.3 Japan
-
2.3.4 Australia and New Zealand
-
-
Asia Pacific Pharmaceutical Blister Packaging Market Size FAQs
How big is the Asia Pacific Pharmaceutical Blister Packaging Market?
The Asia Pacific Pharmaceutical Blister Packaging Market size is expected to reach USD 9.68 billion in 2024 and grow at a CAGR of 6.32% to reach USD 13.16 billion by 2029.
What is the current Asia Pacific Pharmaceutical Blister Packaging Market size?
In 2024, the Asia Pacific Pharmaceutical Blister Packaging Market size is expected to reach USD 9.68 billion.